Talquetamab Versus Real-World Physician's Choice Treatment: Comparative Effectiveness in Patients with Triple-Class Exposed Relapsed/Refractory Multiple Myeloma
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2024）
关键词
G protein–coupled receptor class C group 5 member D (GPRC5D),bispecific antibody,indirect treatment comparison,MonumenTAL-1,Flatiron Health
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要